11.2 Capital is an early-stage venture capital fund based in San Francisco, focusing on global technology startups. They invest in founders solving significant global challenges, with a particular interest in breakthrough technologies across enterprise software, artificial intelligence, and biotechnology sectors. The firm typically participates in seed and Series A rounds, though they have also invested in later stages.
Notable portfolio companies include Ginkgo Bioworks, Hinge Health, and Forter. 11.2 Capital, named after Earth's escape velocity, aims to help startups achieve global impact. Their investment philosophy centers on supporting visionary founders tackling complex problems with innovative solutions, providing both capital and strategic guidance to accelerate growth and market penetration.
11.2 Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Total Investments30
Current Portfolio Count21
Total Portfolio Exits2
Top Investment Stages
Seed13 (46.4%)
Series A8 (28.6%)
Series B4 (14.3%)
Series Unknown2 (7.1%)
Convertible Note1 (3.6%)
Stage Mix
Seed 46%Series A 29%Series B 14%Series Unknown 7%Convertible Note 4%
Concentration shown as share of disclosed investments by stage.
11.2 Capital - Classification
- NAICS
- 520000Finance and Insurance
- 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
- 523900Other Financial Investment Activities
- 523990All Other Financial Investment Activities
- 523999Miscellaneous Financial Investment Activities
- SIC
- 6700Holding And Other Investment Offices
- 6790Miscellaneous Investing
- 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
- NAICS
- 525000Funds, Trusts, and Other Financial Vehicles
- 523910Miscellaneous Intermediation
- 523940Portfolio Management and Investment Advice
- SIC
- 6000Depository Institutions
- 6720Investment Offices
- 6722Management Investment Offices, Open-end